XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows From Operating Activities:    
Net loss $ (25,508) $ (63,312)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation expense 2,529 3,505
Gain on change in fair value of SAFE and warrant liabilities (13,277) (20,979)
Loss on change in fair value of the FPA Put Option and the Fixed Maturity Consideration liabilities 13,045 51,109
Provision for losses on trade and other receivables 0 800
Depreciation of property, plant and equipment 1,530 1,257
Amortization of discount on debt security investment (360) 0
Non-cash lease expense 496 532
Non-cash recognition of licensing revenue (641) (553)
Loss from equity method investees, net 681 608
Net foreign exchange gain (224) (171)
Changes in operating assets and liabilities:    
Accounts receivable, net 645 1,618
Contract assets (1,029) (408)
Accrued interest on debt investment (177) 0
Other assets (3,012) (8,593)
Accounts payable and accrued salaries and wages (2,207) 1,692
Contract liabilities 616 (60)
Operating lease liabilities (485) (667)
Other liabilities (911) (188)
Net cash used in operating activities (28,289) (33,810)
Cash Flows From Investing Activities:    
Purchase of property, plant and equipment (1,480) (1,367)
Purchase of debt securities 0 (49,103)
Proceeds from maturity of debt securities 10,700 0
Net cash provided by/ (used in) investing activities 9,220 (50,470)
Cash Flows From Financing Activities:    
Proceeds from issue of equity instruments of the Company 234 746
Proceeds from the Business Combination and PIPE, net of transaction expenses (Note 3) 0 213,381
Forward Purchase Agreement prepayment 0 (60,096)
Repurchase of equity instruments of the Company (48) (7,650)
Net cash provided by financing activities 186 146,381
Net decrease in cash, cash equivalents and restricted cash (18,883) 62,101
Cash, cash equivalents and restricted cash at beginning of period 76,284 83,710
Effects of currency translation on cash, cash equivalents and restricted cash 48 (25)
Cash, cash equivalents and restricted cash at end of period 57,449 145,786
Supplemental disclosure of non-cash investing and financing activities:    
Acquisition of property, plant and equipment under accounts payable 141 234
Reclassification of capitalized costs related to the business combination to equity 0 1,514
Cashless conversion of warrants on preferred shares 0 5,890
Recognition of public and private warrant liabilities in the Business Combination 0 4,624
Reclassification of AM SAFE warrant to equity 0 1,800
Conversion of AM SAFE liability into common stock 0 29,730
Conversion of Legacy LanzaTech NZ, Inc. preferred stock and in-kind dividend into common stock $ 0 $ 722,160